Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 113 of the 116 references it cites were found in a registry or an index.

Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials

Open access

Abstract

Objective: It is unclear whether blockade of the angiotensin system has effects on mental health. Our objective was to determine the impact of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor (AT1R) blockers on mental health domain of quality of life. Study design: Meta-analysis of published literature. Data sources: PubMed and clinicaltrials.gov databases. The last search was conducted in January 2017. Study selection: Randomized controlled trials comparing any angiotensin converting enzyme inhibitor or AT1R blocker versus placebo or non-angiotensin converting enzyme inhibitor or non-AT1R blocker were selected. Study participants were adults without any major physical symptoms. We adhered to meta-analysis reporting methods as per PRISMA and the Cochrane Collaboration. Data synthesis: Eleven studies were included in the analysis. When compared with placebo or other antihypertensive medications, AT1R blockers and angiotensin converting enzyme inhibitors were associated with improved overall quality of life (standard mean difference = 0.11, 95% confidence interval = [0.08, 0.14], p < 0.0001), positive wellbeing (standard mean difference = 0.11, 95% confidence interval = [0.05, 0.17], p < 0.0001), mental (standard mean difference = 0.15, 95% confidence interval = [0.06, 0.25], p < 0.0001), and anxiety (standard mean difference = 0.08, 95% confidence interval = [0.01, 0.16], p < 0.0001) domains of QoL. No significant difference was found for the depression domain (standard mean difference = 0.05, 95% confidence interval = [0.02, 0.12], p = 0.15). Conclusions: Use of angiotensin blockers and inhibitors for the treatment of hypertension in otherwise healthy adults is associated with improved mental health domains of quality of life. Mental health quality of life was a secondary outcome in the included studies. Research specifically designed to analyse the usefulness of drugs that block the angiotensin system is necessary to properly evaluate this novel psychiatric target.

Overview

Integrity signals

Registry

Crossref · 10.1177/0004867417721654

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 116 references

Research works printed but not linked: 5

  1. Carre A, Petetin N, Jouvent R, et al. (1988) Blood pressure control and quality of life: A comparative multicenter double-blind and cross-over trial of labetalol and captopril. La Revue de Médecine Interne 9: 545–553.
  2. Higgins JPT, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. London: The Cochrane Collaboration.
  3. Jp H (2011) Handbook for Systematic Reviews of Interventions Version 5.1.0. London: The Cochrane Collaboration.
  4. 10.1001/jama.1993.03510060059034 · DOI · Paper page
  5. Os I, Bratland B, Dahlof B, et al. (1991) Lisinopril and nifedipine in essential hypertension: A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients. Journal of Hypertension 9: S382–S383.

Cited by

See all 46

Metadata

Authors
Brownstein, D. J., Salagre, E., Köhler, C., Stubbs, B., Vian, J., Pereira, C., Chavarria, V., Karmakar, C., Turner, A., Quevedo, J., Carvalho, A. F., Berk, M., & Fernandes, B. S.
Affiliations
  • Monash University (AU)
  • Centro de Investigación Biomédica en Red de Salud Mental (ES)
  • Universidade Federal do Ceará (BR)
  • King's College London (GB)
  • University of Lisbon (PT)
  • Parc de Salut (ES)
  • Deakin University (AU)
  • Barwon Health (AU)
  • The University of Texas MD Anderson Cancer Center (US)
  • Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
  • Universidade Federal do Rio Grande do Sul (BR)
Corresponding author
Fernandes, Brisa S
Venue
Australian & New Zealand Journal of Psychiatry
Published
2017-07-28
Volume
52
Issue
1
Pages
24-38
ISSN
  • 0004-8674 (ISSN-L)
  • 1440-1614
OpenAlex
W2740997385
Cited by
46
References
116
Citations by year
2026: 4 · 2025: 6 · 2024: 2 · 2023: 6 · 2022: 10 · 2021: 4 · 2020: 8 · 2019: 1 · 2018: 5
FWCI
0.54
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Australian & New Zealand Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Own your potential (DEAKIN) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
Funders
National Institute for Health and Care Research (ICA-CL-2017-03-001, NIHR-INF-0685)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
ACE inhibitors, angiotensin receptor blockers, quality of life, mental health, well-being, anxiety, depression, hypertension, antihypertensive drugs, psychiatric adverse effects
MeSH terms
Angiotensin-Converting Enzyme Inhibitors, Anxiety, Humans, Hypertension, Mental Health, Quality of Life, Randomized Controlled Trials as Topic, Angiotensin II Type 1 Receptor Blockers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials. https://app.cochat.ai/papers/10.1177/0004867417721654
The paper
Brownstein, D. J., Salagre, E., Köhler, C., Stubbs, B., Vian, J., Pereira, C., Chavarria, V., Karmakar, C., Turner, A., Quevedo, J., Carvalho, A. F., Berk, M., & Fernandes, B. S. (2018). Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867417721654

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.